Metabolic profile of XK469 (2(R)-[4-(7-chloro-2-quinoxalinyl)oxyphenoxy]-propionic acid; NSC698215) in patients and in vitro: low potential for active or toxic metabolites or for drug–drug interactions-Reference-Cited by-同舟云学术

Metabolic profile of XK469 (2(R)-[4-(7-chloro-2-quinoxalinyl)oxyphenoxy]-propionic acid; NSC698215) in patients and in vitro: low potential for active or toxic metabolites or for drug–drug interactions

Published:2005-05-13 Issue:4 Volume:56 Page:351-357
ISSN:0344-5704
Container-title:Cancer Chemotherapy and Pharmacology
language:en
Short-container-title:Cancer Chemother Pharmacol

Author:

Anderson Lawrence W.,Collins Jerry M.,Klecker Raymond W.,Katki Aspandiar G.,Parchment Ralph E.,Boinpally Ramesh R.,LoRusso Patricia M.,Ivy S. Percy

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s00280-004-0962-3.pdf

Reference24 articles.

1. Al-Salmy HS (2001) Individual variation in hepatic aldehyde oxidase activity. IUBMB Life 51:249–253

2. Beedham C, Miceli JJ, Obach RS (2003) Ziprasidone metabolism, aldehyde oxidase, and clinical implications. J Psychopharmacol 23:229–232

3. Chabner BA (2001) Cytidine analogues. In: Chabner BA, Longo DL (eds) Cancer chemotherapy and biotherapy. Lippincott Williams & Wilkins, Philadelphia, pp 213–233

4. Collins JM (2000) Cytochrome P-450 and other determinants of pharmacokinetics, toxicity, and efficacy in humans. Clin Cancer Res 6:1203–1204

5. Collins JM (2000) Prediction of drug interactions from in vitro studies: regulatory viewpoint. In: Levy RH, Thummel KE, Trager WF, Hansten P, Eichelbaum M (eds) Metabolic drug interactions. Lippincott-Raven, Philadelphia, pp 41–47

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparative study on the occurrence of adverse effects in the concomitant use of azathioprine and aldehyde oxidase inhibitors;Expert Opinion on Drug Safety;2023-12-14

2. Challenges and Opportunities for In Vitro–In Vivo Extrapolation of Aldehyde Oxidase-Mediated Clearance: Toward a Roadmap for Quantitative Translation;Drug Metabolism and Disposition;2023-09-26

3. Drug clearance by aldehyde oxidase: can we avoid clinical failure?;Xenobiotica;2022-08-03

4. Roles of selected non-P450 human oxidoreductase enzymes in protective and toxic effects of chemicals: review and compilation of reactions;Archives of Toxicology;2022-06-01

5. Non-cytochrome P450 enzymes involved in the oxidative metabolism of xenobiotics: Focus on the regulation of gene expression and enzyme activity;Pharmacology & Therapeutics;2021-10